Palantir's Two-Sided Story: Blowout Growth, Insider Selling, and a Stock Stretched to Its Limits

Palantir's Q2 revenue surged 93% to $1.94B, but insider selling and a stretched valuation spark debate as Pentagon contracts grow.

The bull case for Palantir has rarely looked stronger on paper. The company just delivered another quarter of accelerating growth, locked in fresh Pentagon funding, and rolled out new product features aimed at keeping enterprise customers hooked. Yet the stock's recent surge has also triggered a familiar counter-narrative: insiders cashing out, valuation skeptics growing louder, and a share price that has run so far, so fast, that even supporters are starting to hedge their enthusiasm.

The Numbers Behind the Rally

Palantir's second-quarter results, released in early August, were nothing short of spectacular. Revenue climbed 93 percent year over year to $1.94 billion, while commercial profits jumped 149 percent to $764 million and government profits rose 90 percent to $809 million. That marks the twelfth consecutive quarter of accelerating growth — a streak that has forced even longtime bears to recalibrate.

CEO Alex Karp described the performance as "otherworldly" and expressed confidence the pace can hold for another 18 months. The market initially rewarded the optimism: shares jumped 16 percent in premarket trading following the release. Citi analysts used the occasion to push back against the most common bear arguments, arguing the growth trajectory justifies the premium multiple.

The momentum isn't a one-off. In the first quarter, Palantir grew revenue 85 percent to $1.63 billion, powered by a 133 percent surge in its US commercial business. The acceleration has been consistent, but so has the debate over whether the stock's valuation can keep pace with the fundamentals.

A Stock Stretched Thin

The numbers tell a story of a share price that has moved far ahead of its own averages. After closing Friday at €160.88, the stock slipped 1.7 percent on Monday to €158.20. Over the past 30 days, however, Palantir has gained roughly 48 percent — a sprint that has left the shares trading 25 percent above their 50-day moving average and 22 percent above the 200-day line.

The Relative Strength Index sits at 65.7, approaching but not yet breaching overbought territory. In US trading, the stock has been testing resistance at $188, with a breakout potentially opening the path toward $200. Support sits at $180.

Macro headwinds are complicating the technical picture. Brent crude climbed above $90 a barrel following a US strike on Iranian positions, and markets now price a 57 percent probability of a Fed rate hike in September. Both factors are dampening risk appetite across the board, limiting near-term upside for high-multiple growth names like Palantir.

The secondary source paints a slightly different technical snapshot, noting a 51 percent monthly gain and an RSI of 69.1 as of Friday's close, with the stock sitting 11 percent below its 52-week high. The discrepancy reflects timing differences, but the conclusion is similar: this is a stock that has moved very far, very quickly.

Pentagon Momentum Builds

On the government side, Palantir's position keeps strengthening. The Maven Smart System, already designated a "Program of Record" in the regular defense budget since March, is now translating that status into concrete numbers. The Pentagon's fiscal 2027 budget proposal allocates $2.30 billion over five years for Maven and the related Joint Fires Network.

William Blair reiterated its "Outperform" rating on August 26, suggesting Maven could exceed $1 billion in annual recurring revenue — a figure the firm describes as grounded in reality rather than hype.

The company also secured a contract framework worth roughly $876 million with Raytheon for the US Army's Distributed Common Ground System. And a recent court ruling striking down Pentagon restrictions on rival Anthropic is seen as indirectly bolstering the position of Palantir's Maven platform in the defense sector.

On the product front, Palantir introduced "AIP Evolve" in late August, a beta feature designed to coordinate fleets of AI agents for autonomous system optimization. The company also expanded its Foundry offering with role-based compute profiles, a technical but meaningful upgrade for large enterprise clients managing access controls.

The Insider Selling Question

For all the operational momentum, the insider activity gives investors pause. CEO Alexander Karp sold nearly 492,000 shares on August 20 for approximately $86.06 million, tied to tax obligations from vesting RSUs under a Rule 10b5-1 plan. Director Alexander D. Moore and Chief Accounting Officer Jeffrey Buckley also offloaded positions during August.

These transactions are formally automated, plan-based sales for tax purposes — which tempers the drama. But the sheer volume of insider selling at a moment when the stock has already surged is hard to ignore.

Seeking Alpha analyst Juxtaposed Ideas downgraded Palantir from "Buy" to "Hold" on August 18, citing the stretched valuation following the post-earnings rally and the persistent insider sales. That call is now more than a month old, but it underscores that valuation concerns were on the table well before they became consensus.

Political Maneuvering and a Rebutted Rumor

Palantir has also been quietly shifting its political posture, with reports indicating increased campaign donations to Democrats ahead of the midterms. That reads as hedging against regulatory risk should control of the House shift — a signal that even the company itself isn't assuming smooth sailing in government business.

On the rumor front, Palantir pushed back against reports that it had lost an $875 million contract with France's domestic intelligence agency DGSI, pointing to a contract extension signed in late 2025. The clarification matters because it shows how quickly unverified claims can move the stock.

Where That Leaves Investors

With a market capitalization of roughly €386.38 billion and a 19 percent gain over twelve months, Palantir remains one of the most debated names in the AI complex. The annualized 30-day volatility of 100 percent captures the tension: opportunity and risk are trading in unusually close quarters.

The fundamental story is intact — growing government contracts, new product capabilities, and at least one analyst house willing to put a $1 billion revenue figure on Maven. But the combination of a white-hot share price, heavy insider selling, and a valuation that leaves little room for error suggests a meaningful portion of the good news is already priced in. For holders, the valuation debate deserves as much attention as the headlines from the Pentagon.